IBDEI00O ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,1070,1,3,0)
;;=3^Secondary malignant neoplasm of left lung
;;^UTILITY(U,$J,358.3,1070,1,4,0)
;;=4^C78.02
;;^UTILITY(U,$J,358.3,1070,2)
;;=^5001336
;;^UTILITY(U,$J,358.3,1071,0)
;;=C78.7^^10^75^12
;;^UTILITY(U,$J,358.3,1071,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1071,1,3,0)
;;=3^Secondary malignant neoplasm of liver and intrahepatic bile duct
;;^UTILITY(U,$J,358.3,1071,1,4,0)
;;=4^C78.7
;;^UTILITY(U,$J,358.3,1071,2)
;;=^5001339
;;^UTILITY(U,$J,358.3,1072,0)
;;=C79.2^^10^75^19
;;^UTILITY(U,$J,358.3,1072,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1072,1,3,0)
;;=3^Secondary malignant neoplasm of skin
;;^UTILITY(U,$J,358.3,1072,1,4,0)
;;=4^C79.2
;;^UTILITY(U,$J,358.3,1072,2)
;;=^267333
;;^UTILITY(U,$J,358.3,1073,0)
;;=C79.31^^10^75^4
;;^UTILITY(U,$J,358.3,1073,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1073,1,3,0)
;;=3^Secondary malignant neoplasm of brain
;;^UTILITY(U,$J,358.3,1073,1,4,0)
;;=4^C79.31
;;^UTILITY(U,$J,358.3,1073,2)
;;=^5001347
;;^UTILITY(U,$J,358.3,1074,0)
;;=C79.32^^10^75^5
;;^UTILITY(U,$J,358.3,1074,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1074,1,3,0)
;;=3^Secondary malignant neoplasm of cerebral meninges
;;^UTILITY(U,$J,358.3,1074,1,4,0)
;;=4^C79.32
;;^UTILITY(U,$J,358.3,1074,2)
;;=^5001348
;;^UTILITY(U,$J,358.3,1075,0)
;;=C79.49^^10^75^16
;;^UTILITY(U,$J,358.3,1075,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1075,1,3,0)
;;=3^Secondary malignant neoplasm of oth parts of nervous system
;;^UTILITY(U,$J,358.3,1075,1,4,0)
;;=4^C79.49
;;^UTILITY(U,$J,358.3,1075,2)
;;=^267335
;;^UTILITY(U,$J,358.3,1076,0)
;;=C79.51^^10^75^2
;;^UTILITY(U,$J,358.3,1076,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1076,1,3,0)
;;=3^Secondary malignant neoplasm of bone
;;^UTILITY(U,$J,358.3,1076,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,1076,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,1077,0)
;;=C79.52^^10^75^3
;;^UTILITY(U,$J,358.3,1077,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1077,1,3,0)
;;=3^Secondary malignant neoplasm of bone marrow
;;^UTILITY(U,$J,358.3,1077,1,4,0)
;;=4^C79.52
;;^UTILITY(U,$J,358.3,1077,2)
;;=^5001351
;;^UTILITY(U,$J,358.3,1078,0)
;;=C79.71^^10^75^17
;;^UTILITY(U,$J,358.3,1078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1078,1,3,0)
;;=3^Secondary malignant neoplasm of right adrenal gland
;;^UTILITY(U,$J,358.3,1078,1,4,0)
;;=4^C79.71
;;^UTILITY(U,$J,358.3,1078,2)
;;=^5001356
;;^UTILITY(U,$J,358.3,1079,0)
;;=C79.72^^10^75^10
;;^UTILITY(U,$J,358.3,1079,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1079,1,3,0)
;;=3^Secondary malignant neoplasm of left adrenal gland
;;^UTILITY(U,$J,358.3,1079,1,4,0)
;;=4^C79.72
;;^UTILITY(U,$J,358.3,1079,2)
;;=^5001357
;;^UTILITY(U,$J,358.3,1080,0)
;;=C77.5^^10^75^8
;;^UTILITY(U,$J,358.3,1080,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1080,1,3,0)
;;=3^Secondary malignant neoplasm of intrapelvic nodes
;;^UTILITY(U,$J,358.3,1080,1,4,0)
;;=4^C77.5
;;^UTILITY(U,$J,358.3,1080,2)
;;=^267319
;;^UTILITY(U,$J,358.3,1081,0)
;;=C48.2^^10^76^26
;;^UTILITY(U,$J,358.3,1081,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1081,1,3,0)
;;=3^Malignant neoplasm of peritoneum, unspecified
;;^UTILITY(U,$J,358.3,1081,1,4,0)
;;=4^C48.2
;;^UTILITY(U,$J,358.3,1081,2)
;;=^5001122
;;^UTILITY(U,$J,358.3,1082,0)
;;=C45.0^^10^76^32
;;^UTILITY(U,$J,358.3,1082,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1082,1,3,0)
;;=3^Mesothelioma of pleura
;;^UTILITY(U,$J,358.3,1082,1,4,0)
;;=4^C45.0
;;^UTILITY(U,$J,358.3,1082,2)
;;=^5001095
;;^UTILITY(U,$J,358.3,1083,0)
;;=C38.4^^10^76^27
;;^UTILITY(U,$J,358.3,1083,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1083,1,3,0)
;;=3^Malignant neoplasm of pleura
;;^UTILITY(U,$J,358.3,1083,1,4,0)
;;=4^C38.4
;;^UTILITY(U,$J,358.3,1083,2)
;;=^267140
;;^UTILITY(U,$J,358.3,1084,0)
;;=C41.9^^10^76^18
;;^UTILITY(U,$J,358.3,1084,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1084,1,3,0)
;;=3^Malignant neoplasm of bone and articular cartilage, unsp
;;^UTILITY(U,$J,358.3,1084,1,4,0)
;;=4^C41.9
;;^UTILITY(U,$J,358.3,1084,2)
;;=^5000993
;;^UTILITY(U,$J,358.3,1085,0)
;;=C49.9^^10^76^21
;;^UTILITY(U,$J,358.3,1085,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1085,1,3,0)
;;=3^Malignant neoplasm of connective and soft tissue, unsp
;;^UTILITY(U,$J,358.3,1085,1,4,0)
;;=4^C49.9
;;^UTILITY(U,$J,358.3,1085,2)
;;=^5001136
;;^UTILITY(U,$J,358.3,1086,0)
;;=C47.9^^10^76^16
;;^UTILITY(U,$J,358.3,1086,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1086,1,3,0)
;;=3^Malig neoplasm of prph nerves and autonm nervous sys, unsp
;;^UTILITY(U,$J,358.3,1086,1,4,0)
;;=4^C47.9
;;^UTILITY(U,$J,358.3,1086,2)
;;=^5001121
;;^UTILITY(U,$J,358.3,1087,0)
;;=C43.9^^10^76^17
;;^UTILITY(U,$J,358.3,1087,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1087,1,3,0)
;;=3^Malignant melanoma of skin, unspecified
;;^UTILITY(U,$J,358.3,1087,1,4,0)
;;=4^C43.9
;;^UTILITY(U,$J,358.3,1087,2)
;;=^5001015
;;^UTILITY(U,$J,358.3,1088,0)
;;=D03.9^^10^76^31
;;^UTILITY(U,$J,358.3,1088,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1088,1,3,0)
;;=3^Melanoma in situ, unspecified
;;^UTILITY(U,$J,358.3,1088,1,4,0)
;;=4^D03.9
;;^UTILITY(U,$J,358.3,1088,2)
;;=^5001908
;;^UTILITY(U,$J,358.3,1089,0)
;;=C44.01^^10^76^4
;;^UTILITY(U,$J,358.3,1089,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1089,1,3,0)
;;=3^Basal cell carcinoma of skin of lip
;;^UTILITY(U,$J,358.3,1089,1,4,0)
;;=4^C44.01
;;^UTILITY(U,$J,358.3,1089,2)
;;=^340464
;;^UTILITY(U,$J,358.3,1090,0)
;;=C44.02^^10^76^36
;;^UTILITY(U,$J,358.3,1090,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1090,1,3,0)
;;=3^Squamous cell carcinoma of skin of lip
;;^UTILITY(U,$J,358.3,1090,1,4,0)
;;=4^C44.02
;;^UTILITY(U,$J,358.3,1090,2)
;;=^340465
;;^UTILITY(U,$J,358.3,1091,0)
;;=C44.310^^10^76^10
;;^UTILITY(U,$J,358.3,1091,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1091,1,3,0)
;;=3^Basal cell carcinoma of skin of unspecified parts of face
;;^UTILITY(U,$J,358.3,1091,1,4,0)
;;=4^C44.310
;;^UTILITY(U,$J,358.3,1091,2)
;;=^5001043
;;^UTILITY(U,$J,358.3,1092,0)
;;=C44.311^^10^76^5
;;^UTILITY(U,$J,358.3,1092,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1092,1,3,0)
;;=3^Basal cell carcinoma of skin of nose
;;^UTILITY(U,$J,358.3,1092,1,4,0)
;;=4^C44.311
;;^UTILITY(U,$J,358.3,1092,2)
;;=^5001044
;;^UTILITY(U,$J,358.3,1093,0)
;;=C44.319^^10^76^6
;;^UTILITY(U,$J,358.3,1093,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1093,1,3,0)
;;=3^Basal cell carcinoma of skin of other parts of face
;;^UTILITY(U,$J,358.3,1093,1,4,0)
;;=4^C44.319
;;^UTILITY(U,$J,358.3,1093,2)
;;=^5001045
;;^UTILITY(U,$J,358.3,1094,0)
;;=C44.320^^10^76^42
;;^UTILITY(U,$J,358.3,1094,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1094,1,3,0)
;;=3^Squamous cell carcinoma of skin of unspecified parts of face
;;^UTILITY(U,$J,358.3,1094,1,4,0)
;;=4^C44.320
;;^UTILITY(U,$J,358.3,1094,2)
;;=^5001046
;;^UTILITY(U,$J,358.3,1095,0)
;;=C44.321^^10^76^37
;;^UTILITY(U,$J,358.3,1095,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1095,1,3,0)
;;=3^Squamous cell carcinoma of skin of nose
;;^UTILITY(U,$J,358.3,1095,1,4,0)
;;=4^C44.321
;;^UTILITY(U,$J,358.3,1095,2)
;;=^5001047
;;^UTILITY(U,$J,358.3,1096,0)
;;=C44.329^^10^76^38
;;^UTILITY(U,$J,358.3,1096,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1096,1,3,0)
;;=3^Squamous cell carcinoma of skin of other parts of face
;;^UTILITY(U,$J,358.3,1096,1,4,0)
;;=4^C44.329
;;^UTILITY(U,$J,358.3,1096,2)
;;=^5001048
;;^UTILITY(U,$J,358.3,1097,0)
;;=C44.41^^10^76^9
;;^UTILITY(U,$J,358.3,1097,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1097,1,3,0)
;;=3^Basal cell carcinoma of skin of scalp and neck
;;^UTILITY(U,$J,358.3,1097,1,4,0)
;;=4^C44.41
;;^UTILITY(U,$J,358.3,1097,2)
;;=^340476
;;^UTILITY(U,$J,358.3,1098,0)
;;=C44.42^^10^76^41
;;^UTILITY(U,$J,358.3,1098,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1098,1,3,0)
;;=3^Squamous cell carcinoma of skin of scalp and neck
;;^UTILITY(U,$J,358.3,1098,1,4,0)
;;=4^C44.42
;;^UTILITY(U,$J,358.3,1098,2)
;;=^340477
;;^UTILITY(U,$J,358.3,1099,0)
;;=C44.510^^10^76^1
;;^UTILITY(U,$J,358.3,1099,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1099,1,3,0)
;;=3^Basal cell carcinoma of anal skin
;;^UTILITY(U,$J,358.3,1099,1,4,0)
;;=4^C44.510
;;^UTILITY(U,$J,358.3,1099,2)
;;=^5001054
;;^UTILITY(U,$J,358.3,1100,0)
;;=C44.511^^10^76^2
;;^UTILITY(U,$J,358.3,1100,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1100,1,3,0)
;;=3^Basal cell carcinoma of skin of breast
;;^UTILITY(U,$J,358.3,1100,1,4,0)
;;=4^C44.511
;;^UTILITY(U,$J,358.3,1100,2)
;;=^5001055
;;^UTILITY(U,$J,358.3,1101,0)
;;=C44.519^^10^76^7
;;^UTILITY(U,$J,358.3,1101,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1101,1,3,0)
;;=3^Basal cell carcinoma of skin of other part of trunk
;;^UTILITY(U,$J,358.3,1101,1,4,0)
;;=4^C44.519
;;^UTILITY(U,$J,358.3,1101,2)
;;=^5001056
;;^UTILITY(U,$J,358.3,1102,0)
;;=C44.520^^10^76^33
;;^UTILITY(U,$J,358.3,1102,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1102,1,3,0)
;;=3^Squamous cell carcinoma of anal skin
;;^UTILITY(U,$J,358.3,1102,1,4,0)
;;=4^C44.520
;;^UTILITY(U,$J,358.3,1102,2)
;;=^5001057
;;^UTILITY(U,$J,358.3,1103,0)
;;=C44.521^^10^76^34
;;^UTILITY(U,$J,358.3,1103,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1103,1,3,0)
;;=3^Squamous cell carcinoma of skin of breast
;;^UTILITY(U,$J,358.3,1103,1,4,0)
;;=4^C44.521
;;^UTILITY(U,$J,358.3,1103,2)
;;=^5001058
;;^UTILITY(U,$J,358.3,1104,0)
;;=C44.529^^10^76^39
;;^UTILITY(U,$J,358.3,1104,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1104,1,3,0)
;;=3^Squamous cell carcinoma of skin of other part of trunk
;;^UTILITY(U,$J,358.3,1104,1,4,0)
;;=4^C44.529
;;^UTILITY(U,$J,358.3,1104,2)
;;=^5001059
;;^UTILITY(U,$J,358.3,1105,0)
;;=C46.9^^10^76^15
;;^UTILITY(U,$J,358.3,1105,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1105,1,3,0)
;;=3^Kaposi's sarcoma, unspecified
;;^UTILITY(U,$J,358.3,1105,1,4,0)
;;=4^C46.9
;;^UTILITY(U,$J,358.3,1105,2)
;;=^5001108
;;^UTILITY(U,$J,358.3,1106,0)
;;=C71.9^^10^76^19
;;^UTILITY(U,$J,358.3,1106,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1106,1,3,0)
;;=3^Malignant neoplasm of brain, unspecified
;;^UTILITY(U,$J,358.3,1106,1,4,0)
;;=4^C71.9
;;^UTILITY(U,$J,358.3,1106,2)
;;=^5001297
;;^UTILITY(U,$J,358.3,1107,0)
;;=C72.1^^10^76^20
;;^UTILITY(U,$J,358.3,1107,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1107,1,3,0)
;;=3^Malignant neoplasm of cauda equina
;;^UTILITY(U,$J,358.3,1107,1,4,0)
;;=4^C72.1
;;^UTILITY(U,$J,358.3,1107,2)
;;=^5001298
;;^UTILITY(U,$J,358.3,1108,0)
;;=C72.0^^10^76^28
;;^UTILITY(U,$J,358.3,1108,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1108,1,3,0)
;;=3^Malignant neoplasm of spinal cord
;;^UTILITY(U,$J,358.3,1108,1,4,0)
;;=4^C72.0
;;^UTILITY(U,$J,358.3,1108,2)
;;=^267292
;;^UTILITY(U,$J,358.3,1109,0)
;;=C74.01^^10^76^23
;;^UTILITY(U,$J,358.3,1109,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1109,1,3,0)
;;=3^Malignant neoplasm of cortex of right adrenal gland
;;^UTILITY(U,$J,358.3,1109,1,4,0)
;;=4^C74.01
;;^UTILITY(U,$J,358.3,1109,2)
;;=^5001312
;;^UTILITY(U,$J,358.3,1110,0)
;;=C74.02^^10^76^22
;;^UTILITY(U,$J,358.3,1110,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1110,1,3,0)
;;=3^Malignant neoplasm of cortex of left adrenal gland
;;^UTILITY(U,$J,358.3,1110,1,4,0)
;;=4^C74.02
;;^UTILITY(U,$J,358.3,1110,2)
;;=^5001313
;;^UTILITY(U,$J,358.3,1111,0)
;;=C74.11^^10^76^25
;;^UTILITY(U,$J,358.3,1111,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1111,1,3,0)
;;=3^Malignant neoplasm of medulla of right adrenal gland
;;^UTILITY(U,$J,358.3,1111,1,4,0)
;;=4^C74.11
;;^UTILITY(U,$J,358.3,1111,2)
;;=^5001315
;;^UTILITY(U,$J,358.3,1112,0)
;;=C74.12^^10^76^24
;;^UTILITY(U,$J,358.3,1112,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1112,1,3,0)
;;=3^Malignant neoplasm of medulla of left adrenal gland
;;^UTILITY(U,$J,358.3,1112,1,4,0)
;;=4^C74.12
;;^UTILITY(U,$J,358.3,1112,2)
;;=^5001316
;;^UTILITY(U,$J,358.3,1113,0)
;;=C74.91^^10^76^30
;;^UTILITY(U,$J,358.3,1113,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1113,1,3,0)
;;=3^Malignant neoplasm of unsp part of right adrenal gland
;;^UTILITY(U,$J,358.3,1113,1,4,0)
;;=4^C74.91
;;^UTILITY(U,$J,358.3,1113,2)
;;=^5001318
;;^UTILITY(U,$J,358.3,1114,0)
;;=C74.92^^10^76^29
;;^UTILITY(U,$J,358.3,1114,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1114,1,3,0)
;;=3^Malignant neoplasm of unsp part of left adrenal gland
;;^UTILITY(U,$J,358.3,1114,1,4,0)
;;=4^C74.92
;;^UTILITY(U,$J,358.3,1114,2)
;;=^5001319
;;^UTILITY(U,$J,358.3,1115,0)
;;=C44.222^^10^76^40
;;^UTILITY(U,$J,358.3,1115,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1115,1,3,0)
;;=3^Squamous cell carcinoma of skin of right ear/external auric canal
;;^UTILITY(U,$J,358.3,1115,1,4,0)
;;=4^C44.222
;;^UTILITY(U,$J,358.3,1115,2)
;;=^5001035
;;^UTILITY(U,$J,358.3,1116,0)
;;=C44.229^^10^76^35
;;^UTILITY(U,$J,358.3,1116,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1116,1,3,0)
;;=3^Squamous cell carcinoma of skin of left ear/external auric canal
;;^UTILITY(U,$J,358.3,1116,1,4,0)
;;=4^C44.229
;;^UTILITY(U,$J,358.3,1116,2)
;;=^5001036
;;^UTILITY(U,$J,358.3,1117,0)
;;=C44.212^^10^76^8
;;^UTILITY(U,$J,358.3,1117,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1117,1,3,0)
;;=3^Basal cell carcinoma of skin of right ear/external auric canal
;;^UTILITY(U,$J,358.3,1117,1,4,0)
;;=4^C44.212
;;^UTILITY(U,$J,358.3,1117,2)
;;=^5001032
;;^UTILITY(U,$J,358.3,1118,0)
;;=C44.219^^10^76^3
;;^UTILITY(U,$J,358.3,1118,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1118,1,3,0)
;;=3^Basal cell carcinoma of skin of left ear/external auric canal
;;^UTILITY(U,$J,358.3,1118,1,4,0)
;;=4^C44.219
;;^UTILITY(U,$J,358.3,1118,2)
;;=^5001033
;;^UTILITY(U,$J,358.3,1119,0)
;;=C44.1191^^10^76^14
;;^UTILITY(U,$J,358.3,1119,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1119,1,3,0)
;;=3^Basal cell cardinoma of skin of left upper eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1119,1,4,0)
;;=4^C44.1191
;;^UTILITY(U,$J,358.3,1119,2)
;;=^5157259
;;^UTILITY(U,$J,358.3,1120,0)
;;=C44.1192^^10^76^11
;;^UTILITY(U,$J,358.3,1120,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1120,1,3,0)
;;=3^Basal cell carcinoma skin of left lower eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1120,1,4,0)
;;=4^C44.1192
;;^UTILITY(U,$J,358.3,1120,2)
;;=^5157260
;;^UTILITY(U,$J,358.3,1121,0)
;;=C44.1122^^10^76^12
;;^UTILITY(U,$J,358.3,1121,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1121,1,3,0)
;;=3^Basal cell carcinoma skin of right lower eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1121,1,4,0)
;;=4^C44.1122
;;^UTILITY(U,$J,358.3,1121,2)
;;=^5157258
;;^UTILITY(U,$J,358.3,1122,0)
;;=C44.1121^^10^76^13
;;^UTILITY(U,$J,358.3,1122,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1122,1,3,0)
;;=3^Basal cell carcinoma skin of right upper eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1122,1,4,0)
;;=4^C44.1121
;;^UTILITY(U,$J,358.3,1122,2)
;;=^5157257
;;^UTILITY(U,$J,358.3,1123,0)
;;=C44.1292^^10^76^43
;;^UTILITY(U,$J,358.3,1123,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1123,1,3,0)
;;=3^Squamous cell carcinoma skin of left lower eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1123,1,4,0)
;;=4^C44.1292
;;^UTILITY(U,$J,358.3,1123,2)
;;=^5157264
;;^UTILITY(U,$J,358.3,1124,0)
;;=C44.1291^^10^76^44
;;^UTILITY(U,$J,358.3,1124,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1124,1,3,0)
;;=3^Squamous cell carcinoma skin of left upper eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1124,1,4,0)
;;=4^C44.1291
;;^UTILITY(U,$J,358.3,1124,2)
;;=^5157263
;;^UTILITY(U,$J,358.3,1125,0)
;;=C44.1222^^10^76^45
;;^UTILITY(U,$J,358.3,1125,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1125,1,3,0)
;;=3^Squamous cell carcinoma skin of right lower eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1125,1,4,0)
;;=4^C44.1222
;;^UTILITY(U,$J,358.3,1125,2)
;;=^5157262
;;^UTILITY(U,$J,358.3,1126,0)
;;=C44.1221^^10^76^46
;;^UTILITY(U,$J,358.3,1126,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1126,1,3,0)
;;=3^Squamous cell carcinoma skin of right upper eyelid,incl canthus
;;^UTILITY(U,$J,358.3,1126,1,4,0)
;;=4^C44.1221
;;^UTILITY(U,$J,358.3,1126,2)
;;=^5157261
;;^UTILITY(U,$J,358.3,1127,0)
;;=C92.40^^10^77^21
;;^UTILITY(U,$J,358.3,1127,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1127,1,3,0)
;;=3^Acute promyelocytic leukemia, not having achieved remission
;;^UTILITY(U,$J,358.3,1127,1,4,0)
;;=4^C92.40
;;^UTILITY(U,$J,358.3,1127,2)
;;=^5001801
;;^UTILITY(U,$J,358.3,1128,0)
;;=C92.50^^10^77^18
;;^UTILITY(U,$J,358.3,1128,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1128,1,3,0)
;;=3^Acute myelomonocytic leukemia, not having achieved remission
;;^UTILITY(U,$J,358.3,1128,1,4,0)
;;=4^C92.50
;;^UTILITY(U,$J,358.3,1128,2)
;;=^5001804
;;^UTILITY(U,$J,358.3,1129,0)
;;=C92.00^^10^77^15
;;^UTILITY(U,$J,358.3,1129,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1129,1,3,0)
;;=3^Acute myeloblastic leukemia, not having achieved remission
;;^UTILITY(U,$J,358.3,1129,1,4,0)
;;=4^C92.00
;;^UTILITY(U,$J,358.3,1129,2)
;;=^5001789
;;^UTILITY(U,$J,358.3,1130,0)
;;=C92.51^^10^77^17
;;^UTILITY(U,$J,358.3,1130,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1130,1,3,0)
;;=3^Acute myelomonocytic leukemia, in remission
;;^UTILITY(U,$J,358.3,1130,1,4,0)
;;=4^C92.51
;;^UTILITY(U,$J,358.3,1130,2)
;;=^5001805
;;^UTILITY(U,$J,358.3,1131,0)
;;=C92.41^^10^77^20
;;^UTILITY(U,$J,358.3,1131,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1131,1,3,0)
;;=3^Acute promyelocytic leukemia, in remission
;;^UTILITY(U,$J,358.3,1131,1,4,0)
;;=4^C92.41
;;^UTILITY(U,$J,358.3,1131,2)
;;=^5001802
;;^UTILITY(U,$J,358.3,1132,0)
;;=C92.01^^10^77^14
;;^UTILITY(U,$J,358.3,1132,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1132,1,3,0)
;;=3^Acute myeloblastic leukemia, in remission
;;^UTILITY(U,$J,358.3,1132,1,4,0)
;;=4^C92.01
;;^UTILITY(U,$J,358.3,1132,2)
;;=^5001790
;;^UTILITY(U,$J,358.3,1133,0)
;;=C92.02^^10^77^13
;;^UTILITY(U,$J,358.3,1133,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1133,1,3,0)
;;=3^Acute myeloblastic leukemia, in relapse
;;^UTILITY(U,$J,358.3,1133,1,4,0)
;;=4^C92.02
;;^UTILITY(U,$J,358.3,1133,2)
;;=^5001791
;;^UTILITY(U,$J,358.3,1134,0)
;;=C92.42^^10^77^19
;;^UTILITY(U,$J,358.3,1134,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1134,1,3,0)
;;=3^Acute promyelocytic leukemia, in relapse
;;^UTILITY(U,$J,358.3,1134,1,4,0)
;;=4^C92.42
;;^UTILITY(U,$J,358.3,1134,2)
;;=^5001803
;;^UTILITY(U,$J,358.3,1135,0)
;;=C92.52^^10^77^16
;;^UTILITY(U,$J,358.3,1135,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,1135,1,3,0)
;;=3^Acute myelomonocytic leukemia, in relapse
;;^UTILITY(U,$J,358.3,1135,1,4,0)
;;=4^C92.52
;;^UTILITY(U,$J,358.3,1135,2)
;;=^5001806
;;^UTILITY(U,$J,358.3,1136,0)
;;=C92.10^^10^77^28
;;^UTILITY(U,$J,358.3,1136,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI00O 19746 printed Apr 09, 2024@21:18:30 Page 2
IBDEI00O ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,1070,1,3,0)
+2 ;;=3^Secondary malignant neoplasm of left lung
+3 ;;^UTILITY(U,$J,358.3,1070,1,4,0)
+4 ;;=4^C78.02
+5 ;;^UTILITY(U,$J,358.3,1070,2)
+6 ;;=^5001336
+7 ;;^UTILITY(U,$J,358.3,1071,0)
+8 ;;=C78.7^^10^75^12
+9 ;;^UTILITY(U,$J,358.3,1071,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,1071,1,3,0)
+12 ;;=3^Secondary malignant neoplasm of liver and intrahepatic bile duct
+13 ;;^UTILITY(U,$J,358.3,1071,1,4,0)
+14 ;;=4^C78.7
+15 ;;^UTILITY(U,$J,358.3,1071,2)
+16 ;;=^5001339
+17 ;;^UTILITY(U,$J,358.3,1072,0)
+18 ;;=C79.2^^10^75^19
+19 ;;^UTILITY(U,$J,358.3,1072,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,1072,1,3,0)
+22 ;;=3^Secondary malignant neoplasm of skin
+23 ;;^UTILITY(U,$J,358.3,1072,1,4,0)
+24 ;;=4^C79.2
+25 ;;^UTILITY(U,$J,358.3,1072,2)
+26 ;;=^267333
+27 ;;^UTILITY(U,$J,358.3,1073,0)
+28 ;;=C79.31^^10^75^4
+29 ;;^UTILITY(U,$J,358.3,1073,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,1073,1,3,0)
+32 ;;=3^Secondary malignant neoplasm of brain
+33 ;;^UTILITY(U,$J,358.3,1073,1,4,0)
+34 ;;=4^C79.31
+35 ;;^UTILITY(U,$J,358.3,1073,2)
+36 ;;=^5001347
+37 ;;^UTILITY(U,$J,358.3,1074,0)
+38 ;;=C79.32^^10^75^5
+39 ;;^UTILITY(U,$J,358.3,1074,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,1074,1,3,0)
+42 ;;=3^Secondary malignant neoplasm of cerebral meninges
+43 ;;^UTILITY(U,$J,358.3,1074,1,4,0)
+44 ;;=4^C79.32
+45 ;;^UTILITY(U,$J,358.3,1074,2)
+46 ;;=^5001348
+47 ;;^UTILITY(U,$J,358.3,1075,0)
+48 ;;=C79.49^^10^75^16
+49 ;;^UTILITY(U,$J,358.3,1075,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,1075,1,3,0)
+52 ;;=3^Secondary malignant neoplasm of oth parts of nervous system
+53 ;;^UTILITY(U,$J,358.3,1075,1,4,0)
+54 ;;=4^C79.49
+55 ;;^UTILITY(U,$J,358.3,1075,2)
+56 ;;=^267335
+57 ;;^UTILITY(U,$J,358.3,1076,0)
+58 ;;=C79.51^^10^75^2
+59 ;;^UTILITY(U,$J,358.3,1076,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,1076,1,3,0)
+62 ;;=3^Secondary malignant neoplasm of bone
+63 ;;^UTILITY(U,$J,358.3,1076,1,4,0)
+64 ;;=4^C79.51
+65 ;;^UTILITY(U,$J,358.3,1076,2)
+66 ;;=^5001350
+67 ;;^UTILITY(U,$J,358.3,1077,0)
+68 ;;=C79.52^^10^75^3
+69 ;;^UTILITY(U,$J,358.3,1077,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,1077,1,3,0)
+72 ;;=3^Secondary malignant neoplasm of bone marrow
+73 ;;^UTILITY(U,$J,358.3,1077,1,4,0)
+74 ;;=4^C79.52
+75 ;;^UTILITY(U,$J,358.3,1077,2)
+76 ;;=^5001351
+77 ;;^UTILITY(U,$J,358.3,1078,0)
+78 ;;=C79.71^^10^75^17
+79 ;;^UTILITY(U,$J,358.3,1078,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,1078,1,3,0)
+82 ;;=3^Secondary malignant neoplasm of right adrenal gland
+83 ;;^UTILITY(U,$J,358.3,1078,1,4,0)
+84 ;;=4^C79.71
+85 ;;^UTILITY(U,$J,358.3,1078,2)
+86 ;;=^5001356
+87 ;;^UTILITY(U,$J,358.3,1079,0)
+88 ;;=C79.72^^10^75^10
+89 ;;^UTILITY(U,$J,358.3,1079,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,1079,1,3,0)
+92 ;;=3^Secondary malignant neoplasm of left adrenal gland
+93 ;;^UTILITY(U,$J,358.3,1079,1,4,0)
+94 ;;=4^C79.72
+95 ;;^UTILITY(U,$J,358.3,1079,2)
+96 ;;=^5001357
+97 ;;^UTILITY(U,$J,358.3,1080,0)
+98 ;;=C77.5^^10^75^8
+99 ;;^UTILITY(U,$J,358.3,1080,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,1080,1,3,0)
+102 ;;=3^Secondary malignant neoplasm of intrapelvic nodes
+103 ;;^UTILITY(U,$J,358.3,1080,1,4,0)
+104 ;;=4^C77.5
+105 ;;^UTILITY(U,$J,358.3,1080,2)
+106 ;;=^267319
+107 ;;^UTILITY(U,$J,358.3,1081,0)
+108 ;;=C48.2^^10^76^26
+109 ;;^UTILITY(U,$J,358.3,1081,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,1081,1,3,0)
+112 ;;=3^Malignant neoplasm of peritoneum, unspecified
+113 ;;^UTILITY(U,$J,358.3,1081,1,4,0)
+114 ;;=4^C48.2
+115 ;;^UTILITY(U,$J,358.3,1081,2)
+116 ;;=^5001122
+117 ;;^UTILITY(U,$J,358.3,1082,0)
+118 ;;=C45.0^^10^76^32
+119 ;;^UTILITY(U,$J,358.3,1082,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,1082,1,3,0)
+122 ;;=3^Mesothelioma of pleura
+123 ;;^UTILITY(U,$J,358.3,1082,1,4,0)
+124 ;;=4^C45.0
+125 ;;^UTILITY(U,$J,358.3,1082,2)
+126 ;;=^5001095
+127 ;;^UTILITY(U,$J,358.3,1083,0)
+128 ;;=C38.4^^10^76^27
+129 ;;^UTILITY(U,$J,358.3,1083,1,0)
+130 ;;=^358.31IA^4^2
+131 ;;^UTILITY(U,$J,358.3,1083,1,3,0)
+132 ;;=3^Malignant neoplasm of pleura
+133 ;;^UTILITY(U,$J,358.3,1083,1,4,0)
+134 ;;=4^C38.4
+135 ;;^UTILITY(U,$J,358.3,1083,2)
+136 ;;=^267140
+137 ;;^UTILITY(U,$J,358.3,1084,0)
+138 ;;=C41.9^^10^76^18
+139 ;;^UTILITY(U,$J,358.3,1084,1,0)
+140 ;;=^358.31IA^4^2
+141 ;;^UTILITY(U,$J,358.3,1084,1,3,0)
+142 ;;=3^Malignant neoplasm of bone and articular cartilage, unsp
+143 ;;^UTILITY(U,$J,358.3,1084,1,4,0)
+144 ;;=4^C41.9
+145 ;;^UTILITY(U,$J,358.3,1084,2)
+146 ;;=^5000993
+147 ;;^UTILITY(U,$J,358.3,1085,0)
+148 ;;=C49.9^^10^76^21
+149 ;;^UTILITY(U,$J,358.3,1085,1,0)
+150 ;;=^358.31IA^4^2
+151 ;;^UTILITY(U,$J,358.3,1085,1,3,0)
+152 ;;=3^Malignant neoplasm of connective and soft tissue, unsp
+153 ;;^UTILITY(U,$J,358.3,1085,1,4,0)
+154 ;;=4^C49.9
+155 ;;^UTILITY(U,$J,358.3,1085,2)
+156 ;;=^5001136
+157 ;;^UTILITY(U,$J,358.3,1086,0)
+158 ;;=C47.9^^10^76^16
+159 ;;^UTILITY(U,$J,358.3,1086,1,0)
+160 ;;=^358.31IA^4^2
+161 ;;^UTILITY(U,$J,358.3,1086,1,3,0)
+162 ;;=3^Malig neoplasm of prph nerves and autonm nervous sys, unsp
+163 ;;^UTILITY(U,$J,358.3,1086,1,4,0)
+164 ;;=4^C47.9
+165 ;;^UTILITY(U,$J,358.3,1086,2)
+166 ;;=^5001121
+167 ;;^UTILITY(U,$J,358.3,1087,0)
+168 ;;=C43.9^^10^76^17
+169 ;;^UTILITY(U,$J,358.3,1087,1,0)
+170 ;;=^358.31IA^4^2
+171 ;;^UTILITY(U,$J,358.3,1087,1,3,0)
+172 ;;=3^Malignant melanoma of skin, unspecified
+173 ;;^UTILITY(U,$J,358.3,1087,1,4,0)
+174 ;;=4^C43.9
+175 ;;^UTILITY(U,$J,358.3,1087,2)
+176 ;;=^5001015
+177 ;;^UTILITY(U,$J,358.3,1088,0)
+178 ;;=D03.9^^10^76^31
+179 ;;^UTILITY(U,$J,358.3,1088,1,0)
+180 ;;=^358.31IA^4^2
+181 ;;^UTILITY(U,$J,358.3,1088,1,3,0)
+182 ;;=3^Melanoma in situ, unspecified
+183 ;;^UTILITY(U,$J,358.3,1088,1,4,0)
+184 ;;=4^D03.9
+185 ;;^UTILITY(U,$J,358.3,1088,2)
+186 ;;=^5001908
+187 ;;^UTILITY(U,$J,358.3,1089,0)
+188 ;;=C44.01^^10^76^4
+189 ;;^UTILITY(U,$J,358.3,1089,1,0)
+190 ;;=^358.31IA^4^2
+191 ;;^UTILITY(U,$J,358.3,1089,1,3,0)
+192 ;;=3^Basal cell carcinoma of skin of lip
+193 ;;^UTILITY(U,$J,358.3,1089,1,4,0)
+194 ;;=4^C44.01
+195 ;;^UTILITY(U,$J,358.3,1089,2)
+196 ;;=^340464
+197 ;;^UTILITY(U,$J,358.3,1090,0)
+198 ;;=C44.02^^10^76^36
+199 ;;^UTILITY(U,$J,358.3,1090,1,0)
+200 ;;=^358.31IA^4^2
+201 ;;^UTILITY(U,$J,358.3,1090,1,3,0)
+202 ;;=3^Squamous cell carcinoma of skin of lip
+203 ;;^UTILITY(U,$J,358.3,1090,1,4,0)
+204 ;;=4^C44.02
+205 ;;^UTILITY(U,$J,358.3,1090,2)
+206 ;;=^340465
+207 ;;^UTILITY(U,$J,358.3,1091,0)
+208 ;;=C44.310^^10^76^10
+209 ;;^UTILITY(U,$J,358.3,1091,1,0)
+210 ;;=^358.31IA^4^2
+211 ;;^UTILITY(U,$J,358.3,1091,1,3,0)
+212 ;;=3^Basal cell carcinoma of skin of unspecified parts of face
+213 ;;^UTILITY(U,$J,358.3,1091,1,4,0)
+214 ;;=4^C44.310
+215 ;;^UTILITY(U,$J,358.3,1091,2)
+216 ;;=^5001043
+217 ;;^UTILITY(U,$J,358.3,1092,0)
+218 ;;=C44.311^^10^76^5
+219 ;;^UTILITY(U,$J,358.3,1092,1,0)
+220 ;;=^358.31IA^4^2
+221 ;;^UTILITY(U,$J,358.3,1092,1,3,0)
+222 ;;=3^Basal cell carcinoma of skin of nose
+223 ;;^UTILITY(U,$J,358.3,1092,1,4,0)
+224 ;;=4^C44.311
+225 ;;^UTILITY(U,$J,358.3,1092,2)
+226 ;;=^5001044
+227 ;;^UTILITY(U,$J,358.3,1093,0)
+228 ;;=C44.319^^10^76^6
+229 ;;^UTILITY(U,$J,358.3,1093,1,0)
+230 ;;=^358.31IA^4^2
+231 ;;^UTILITY(U,$J,358.3,1093,1,3,0)
+232 ;;=3^Basal cell carcinoma of skin of other parts of face
+233 ;;^UTILITY(U,$J,358.3,1093,1,4,0)
+234 ;;=4^C44.319
+235 ;;^UTILITY(U,$J,358.3,1093,2)
+236 ;;=^5001045
+237 ;;^UTILITY(U,$J,358.3,1094,0)
+238 ;;=C44.320^^10^76^42
+239 ;;^UTILITY(U,$J,358.3,1094,1,0)
+240 ;;=^358.31IA^4^2
+241 ;;^UTILITY(U,$J,358.3,1094,1,3,0)
+242 ;;=3^Squamous cell carcinoma of skin of unspecified parts of face
+243 ;;^UTILITY(U,$J,358.3,1094,1,4,0)
+244 ;;=4^C44.320
+245 ;;^UTILITY(U,$J,358.3,1094,2)
+246 ;;=^5001046
+247 ;;^UTILITY(U,$J,358.3,1095,0)
+248 ;;=C44.321^^10^76^37
+249 ;;^UTILITY(U,$J,358.3,1095,1,0)
+250 ;;=^358.31IA^4^2
+251 ;;^UTILITY(U,$J,358.3,1095,1,3,0)
+252 ;;=3^Squamous cell carcinoma of skin of nose
+253 ;;^UTILITY(U,$J,358.3,1095,1,4,0)
+254 ;;=4^C44.321
+255 ;;^UTILITY(U,$J,358.3,1095,2)
+256 ;;=^5001047
+257 ;;^UTILITY(U,$J,358.3,1096,0)
+258 ;;=C44.329^^10^76^38
+259 ;;^UTILITY(U,$J,358.3,1096,1,0)
+260 ;;=^358.31IA^4^2
+261 ;;^UTILITY(U,$J,358.3,1096,1,3,0)
+262 ;;=3^Squamous cell carcinoma of skin of other parts of face
+263 ;;^UTILITY(U,$J,358.3,1096,1,4,0)
+264 ;;=4^C44.329
+265 ;;^UTILITY(U,$J,358.3,1096,2)
+266 ;;=^5001048
+267 ;;^UTILITY(U,$J,358.3,1097,0)
+268 ;;=C44.41^^10^76^9
+269 ;;^UTILITY(U,$J,358.3,1097,1,0)
+270 ;;=^358.31IA^4^2
+271 ;;^UTILITY(U,$J,358.3,1097,1,3,0)
+272 ;;=3^Basal cell carcinoma of skin of scalp and neck
+273 ;;^UTILITY(U,$J,358.3,1097,1,4,0)
+274 ;;=4^C44.41
+275 ;;^UTILITY(U,$J,358.3,1097,2)
+276 ;;=^340476
+277 ;;^UTILITY(U,$J,358.3,1098,0)
+278 ;;=C44.42^^10^76^41
+279 ;;^UTILITY(U,$J,358.3,1098,1,0)
+280 ;;=^358.31IA^4^2
+281 ;;^UTILITY(U,$J,358.3,1098,1,3,0)
+282 ;;=3^Squamous cell carcinoma of skin of scalp and neck
+283 ;;^UTILITY(U,$J,358.3,1098,1,4,0)
+284 ;;=4^C44.42
+285 ;;^UTILITY(U,$J,358.3,1098,2)
+286 ;;=^340477
+287 ;;^UTILITY(U,$J,358.3,1099,0)
+288 ;;=C44.510^^10^76^1
+289 ;;^UTILITY(U,$J,358.3,1099,1,0)
+290 ;;=^358.31IA^4^2
+291 ;;^UTILITY(U,$J,358.3,1099,1,3,0)
+292 ;;=3^Basal cell carcinoma of anal skin
+293 ;;^UTILITY(U,$J,358.3,1099,1,4,0)
+294 ;;=4^C44.510
+295 ;;^UTILITY(U,$J,358.3,1099,2)
+296 ;;=^5001054
+297 ;;^UTILITY(U,$J,358.3,1100,0)
+298 ;;=C44.511^^10^76^2
+299 ;;^UTILITY(U,$J,358.3,1100,1,0)
+300 ;;=^358.31IA^4^2
+301 ;;^UTILITY(U,$J,358.3,1100,1,3,0)
+302 ;;=3^Basal cell carcinoma of skin of breast
+303 ;;^UTILITY(U,$J,358.3,1100,1,4,0)
+304 ;;=4^C44.511
+305 ;;^UTILITY(U,$J,358.3,1100,2)
+306 ;;=^5001055
+307 ;;^UTILITY(U,$J,358.3,1101,0)
+308 ;;=C44.519^^10^76^7
+309 ;;^UTILITY(U,$J,358.3,1101,1,0)
+310 ;;=^358.31IA^4^2
+311 ;;^UTILITY(U,$J,358.3,1101,1,3,0)
+312 ;;=3^Basal cell carcinoma of skin of other part of trunk
+313 ;;^UTILITY(U,$J,358.3,1101,1,4,0)
+314 ;;=4^C44.519
+315 ;;^UTILITY(U,$J,358.3,1101,2)
+316 ;;=^5001056
+317 ;;^UTILITY(U,$J,358.3,1102,0)
+318 ;;=C44.520^^10^76^33
+319 ;;^UTILITY(U,$J,358.3,1102,1,0)
+320 ;;=^358.31IA^4^2
+321 ;;^UTILITY(U,$J,358.3,1102,1,3,0)
+322 ;;=3^Squamous cell carcinoma of anal skin
+323 ;;^UTILITY(U,$J,358.3,1102,1,4,0)
+324 ;;=4^C44.520
+325 ;;^UTILITY(U,$J,358.3,1102,2)
+326 ;;=^5001057
+327 ;;^UTILITY(U,$J,358.3,1103,0)
+328 ;;=C44.521^^10^76^34
+329 ;;^UTILITY(U,$J,358.3,1103,1,0)
+330 ;;=^358.31IA^4^2
+331 ;;^UTILITY(U,$J,358.3,1103,1,3,0)
+332 ;;=3^Squamous cell carcinoma of skin of breast
+333 ;;^UTILITY(U,$J,358.3,1103,1,4,0)
+334 ;;=4^C44.521
+335 ;;^UTILITY(U,$J,358.3,1103,2)
+336 ;;=^5001058
+337 ;;^UTILITY(U,$J,358.3,1104,0)
+338 ;;=C44.529^^10^76^39
+339 ;;^UTILITY(U,$J,358.3,1104,1,0)
+340 ;;=^358.31IA^4^2
+341 ;;^UTILITY(U,$J,358.3,1104,1,3,0)
+342 ;;=3^Squamous cell carcinoma of skin of other part of trunk
+343 ;;^UTILITY(U,$J,358.3,1104,1,4,0)
+344 ;;=4^C44.529
+345 ;;^UTILITY(U,$J,358.3,1104,2)
+346 ;;=^5001059
+347 ;;^UTILITY(U,$J,358.3,1105,0)
+348 ;;=C46.9^^10^76^15
+349 ;;^UTILITY(U,$J,358.3,1105,1,0)
+350 ;;=^358.31IA^4^2
+351 ;;^UTILITY(U,$J,358.3,1105,1,3,0)
+352 ;;=3^Kaposi's sarcoma, unspecified
+353 ;;^UTILITY(U,$J,358.3,1105,1,4,0)
+354 ;;=4^C46.9
+355 ;;^UTILITY(U,$J,358.3,1105,2)
+356 ;;=^5001108
+357 ;;^UTILITY(U,$J,358.3,1106,0)
+358 ;;=C71.9^^10^76^19
+359 ;;^UTILITY(U,$J,358.3,1106,1,0)
+360 ;;=^358.31IA^4^2
+361 ;;^UTILITY(U,$J,358.3,1106,1,3,0)
+362 ;;=3^Malignant neoplasm of brain, unspecified
+363 ;;^UTILITY(U,$J,358.3,1106,1,4,0)
+364 ;;=4^C71.9
+365 ;;^UTILITY(U,$J,358.3,1106,2)
+366 ;;=^5001297
+367 ;;^UTILITY(U,$J,358.3,1107,0)
+368 ;;=C72.1^^10^76^20
+369 ;;^UTILITY(U,$J,358.3,1107,1,0)
+370 ;;=^358.31IA^4^2
+371 ;;^UTILITY(U,$J,358.3,1107,1,3,0)
+372 ;;=3^Malignant neoplasm of cauda equina
+373 ;;^UTILITY(U,$J,358.3,1107,1,4,0)
+374 ;;=4^C72.1
+375 ;;^UTILITY(U,$J,358.3,1107,2)
+376 ;;=^5001298
+377 ;;^UTILITY(U,$J,358.3,1108,0)
+378 ;;=C72.0^^10^76^28
+379 ;;^UTILITY(U,$J,358.3,1108,1,0)
+380 ;;=^358.31IA^4^2
+381 ;;^UTILITY(U,$J,358.3,1108,1,3,0)
+382 ;;=3^Malignant neoplasm of spinal cord
+383 ;;^UTILITY(U,$J,358.3,1108,1,4,0)
+384 ;;=4^C72.0
+385 ;;^UTILITY(U,$J,358.3,1108,2)
+386 ;;=^267292
+387 ;;^UTILITY(U,$J,358.3,1109,0)
+388 ;;=C74.01^^10^76^23
+389 ;;^UTILITY(U,$J,358.3,1109,1,0)
+390 ;;=^358.31IA^4^2
+391 ;;^UTILITY(U,$J,358.3,1109,1,3,0)
+392 ;;=3^Malignant neoplasm of cortex of right adrenal gland
+393 ;;^UTILITY(U,$J,358.3,1109,1,4,0)
+394 ;;=4^C74.01
+395 ;;^UTILITY(U,$J,358.3,1109,2)
+396 ;;=^5001312
+397 ;;^UTILITY(U,$J,358.3,1110,0)
+398 ;;=C74.02^^10^76^22
+399 ;;^UTILITY(U,$J,358.3,1110,1,0)
+400 ;;=^358.31IA^4^2
+401 ;;^UTILITY(U,$J,358.3,1110,1,3,0)
+402 ;;=3^Malignant neoplasm of cortex of left adrenal gland
+403 ;;^UTILITY(U,$J,358.3,1110,1,4,0)
+404 ;;=4^C74.02
+405 ;;^UTILITY(U,$J,358.3,1110,2)
+406 ;;=^5001313
+407 ;;^UTILITY(U,$J,358.3,1111,0)
+408 ;;=C74.11^^10^76^25
+409 ;;^UTILITY(U,$J,358.3,1111,1,0)
+410 ;;=^358.31IA^4^2
+411 ;;^UTILITY(U,$J,358.3,1111,1,3,0)
+412 ;;=3^Malignant neoplasm of medulla of right adrenal gland
+413 ;;^UTILITY(U,$J,358.3,1111,1,4,0)
+414 ;;=4^C74.11
+415 ;;^UTILITY(U,$J,358.3,1111,2)
+416 ;;=^5001315
+417 ;;^UTILITY(U,$J,358.3,1112,0)
+418 ;;=C74.12^^10^76^24
+419 ;;^UTILITY(U,$J,358.3,1112,1,0)
+420 ;;=^358.31IA^4^2
+421 ;;^UTILITY(U,$J,358.3,1112,1,3,0)
+422 ;;=3^Malignant neoplasm of medulla of left adrenal gland
+423 ;;^UTILITY(U,$J,358.3,1112,1,4,0)
+424 ;;=4^C74.12
+425 ;;^UTILITY(U,$J,358.3,1112,2)
+426 ;;=^5001316
+427 ;;^UTILITY(U,$J,358.3,1113,0)
+428 ;;=C74.91^^10^76^30
+429 ;;^UTILITY(U,$J,358.3,1113,1,0)
+430 ;;=^358.31IA^4^2
+431 ;;^UTILITY(U,$J,358.3,1113,1,3,0)
+432 ;;=3^Malignant neoplasm of unsp part of right adrenal gland
+433 ;;^UTILITY(U,$J,358.3,1113,1,4,0)
+434 ;;=4^C74.91
+435 ;;^UTILITY(U,$J,358.3,1113,2)
+436 ;;=^5001318
+437 ;;^UTILITY(U,$J,358.3,1114,0)
+438 ;;=C74.92^^10^76^29
+439 ;;^UTILITY(U,$J,358.3,1114,1,0)
+440 ;;=^358.31IA^4^2
+441 ;;^UTILITY(U,$J,358.3,1114,1,3,0)
+442 ;;=3^Malignant neoplasm of unsp part of left adrenal gland
+443 ;;^UTILITY(U,$J,358.3,1114,1,4,0)
+444 ;;=4^C74.92
+445 ;;^UTILITY(U,$J,358.3,1114,2)
+446 ;;=^5001319
+447 ;;^UTILITY(U,$J,358.3,1115,0)
+448 ;;=C44.222^^10^76^40
+449 ;;^UTILITY(U,$J,358.3,1115,1,0)
+450 ;;=^358.31IA^4^2
+451 ;;^UTILITY(U,$J,358.3,1115,1,3,0)
+452 ;;=3^Squamous cell carcinoma of skin of right ear/external auric canal
+453 ;;^UTILITY(U,$J,358.3,1115,1,4,0)
+454 ;;=4^C44.222
+455 ;;^UTILITY(U,$J,358.3,1115,2)
+456 ;;=^5001035
+457 ;;^UTILITY(U,$J,358.3,1116,0)
+458 ;;=C44.229^^10^76^35
+459 ;;^UTILITY(U,$J,358.3,1116,1,0)
+460 ;;=^358.31IA^4^2
+461 ;;^UTILITY(U,$J,358.3,1116,1,3,0)
+462 ;;=3^Squamous cell carcinoma of skin of left ear/external auric canal
+463 ;;^UTILITY(U,$J,358.3,1116,1,4,0)
+464 ;;=4^C44.229
+465 ;;^UTILITY(U,$J,358.3,1116,2)
+466 ;;=^5001036
+467 ;;^UTILITY(U,$J,358.3,1117,0)
+468 ;;=C44.212^^10^76^8
+469 ;;^UTILITY(U,$J,358.3,1117,1,0)
+470 ;;=^358.31IA^4^2
+471 ;;^UTILITY(U,$J,358.3,1117,1,3,0)
+472 ;;=3^Basal cell carcinoma of skin of right ear/external auric canal
+473 ;;^UTILITY(U,$J,358.3,1117,1,4,0)
+474 ;;=4^C44.212
+475 ;;^UTILITY(U,$J,358.3,1117,2)
+476 ;;=^5001032
+477 ;;^UTILITY(U,$J,358.3,1118,0)
+478 ;;=C44.219^^10^76^3
+479 ;;^UTILITY(U,$J,358.3,1118,1,0)
+480 ;;=^358.31IA^4^2
+481 ;;^UTILITY(U,$J,358.3,1118,1,3,0)
+482 ;;=3^Basal cell carcinoma of skin of left ear/external auric canal
+483 ;;^UTILITY(U,$J,358.3,1118,1,4,0)
+484 ;;=4^C44.219
+485 ;;^UTILITY(U,$J,358.3,1118,2)
+486 ;;=^5001033
+487 ;;^UTILITY(U,$J,358.3,1119,0)
+488 ;;=C44.1191^^10^76^14
+489 ;;^UTILITY(U,$J,358.3,1119,1,0)
+490 ;;=^358.31IA^4^2
+491 ;;^UTILITY(U,$J,358.3,1119,1,3,0)
+492 ;;=3^Basal cell cardinoma of skin of left upper eyelid,incl canthus
+493 ;;^UTILITY(U,$J,358.3,1119,1,4,0)
+494 ;;=4^C44.1191
+495 ;;^UTILITY(U,$J,358.3,1119,2)
+496 ;;=^5157259
+497 ;;^UTILITY(U,$J,358.3,1120,0)
+498 ;;=C44.1192^^10^76^11
+499 ;;^UTILITY(U,$J,358.3,1120,1,0)
+500 ;;=^358.31IA^4^2
+501 ;;^UTILITY(U,$J,358.3,1120,1,3,0)
+502 ;;=3^Basal cell carcinoma skin of left lower eyelid,incl canthus
+503 ;;^UTILITY(U,$J,358.3,1120,1,4,0)
+504 ;;=4^C44.1192
+505 ;;^UTILITY(U,$J,358.3,1120,2)
+506 ;;=^5157260
+507 ;;^UTILITY(U,$J,358.3,1121,0)
+508 ;;=C44.1122^^10^76^12
+509 ;;^UTILITY(U,$J,358.3,1121,1,0)
+510 ;;=^358.31IA^4^2
+511 ;;^UTILITY(U,$J,358.3,1121,1,3,0)
+512 ;;=3^Basal cell carcinoma skin of right lower eyelid,incl canthus
+513 ;;^UTILITY(U,$J,358.3,1121,1,4,0)
+514 ;;=4^C44.1122
+515 ;;^UTILITY(U,$J,358.3,1121,2)
+516 ;;=^5157258
+517 ;;^UTILITY(U,$J,358.3,1122,0)
+518 ;;=C44.1121^^10^76^13
+519 ;;^UTILITY(U,$J,358.3,1122,1,0)
+520 ;;=^358.31IA^4^2
+521 ;;^UTILITY(U,$J,358.3,1122,1,3,0)
+522 ;;=3^Basal cell carcinoma skin of right upper eyelid,incl canthus
+523 ;;^UTILITY(U,$J,358.3,1122,1,4,0)
+524 ;;=4^C44.1121
+525 ;;^UTILITY(U,$J,358.3,1122,2)
+526 ;;=^5157257
+527 ;;^UTILITY(U,$J,358.3,1123,0)
+528 ;;=C44.1292^^10^76^43
+529 ;;^UTILITY(U,$J,358.3,1123,1,0)
+530 ;;=^358.31IA^4^2
+531 ;;^UTILITY(U,$J,358.3,1123,1,3,0)
+532 ;;=3^Squamous cell carcinoma skin of left lower eyelid,incl canthus
+533 ;;^UTILITY(U,$J,358.3,1123,1,4,0)
+534 ;;=4^C44.1292
+535 ;;^UTILITY(U,$J,358.3,1123,2)
+536 ;;=^5157264
+537 ;;^UTILITY(U,$J,358.3,1124,0)
+538 ;;=C44.1291^^10^76^44
+539 ;;^UTILITY(U,$J,358.3,1124,1,0)
+540 ;;=^358.31IA^4^2
+541 ;;^UTILITY(U,$J,358.3,1124,1,3,0)
+542 ;;=3^Squamous cell carcinoma skin of left upper eyelid,incl canthus
+543 ;;^UTILITY(U,$J,358.3,1124,1,4,0)
+544 ;;=4^C44.1291
+545 ;;^UTILITY(U,$J,358.3,1124,2)
+546 ;;=^5157263
+547 ;;^UTILITY(U,$J,358.3,1125,0)
+548 ;;=C44.1222^^10^76^45
+549 ;;^UTILITY(U,$J,358.3,1125,1,0)
+550 ;;=^358.31IA^4^2
+551 ;;^UTILITY(U,$J,358.3,1125,1,3,0)
+552 ;;=3^Squamous cell carcinoma skin of right lower eyelid,incl canthus
+553 ;;^UTILITY(U,$J,358.3,1125,1,4,0)
+554 ;;=4^C44.1222
+555 ;;^UTILITY(U,$J,358.3,1125,2)
+556 ;;=^5157262
+557 ;;^UTILITY(U,$J,358.3,1126,0)
+558 ;;=C44.1221^^10^76^46
+559 ;;^UTILITY(U,$J,358.3,1126,1,0)
+560 ;;=^358.31IA^4^2
+561 ;;^UTILITY(U,$J,358.3,1126,1,3,0)
+562 ;;=3^Squamous cell carcinoma skin of right upper eyelid,incl canthus
+563 ;;^UTILITY(U,$J,358.3,1126,1,4,0)
+564 ;;=4^C44.1221
+565 ;;^UTILITY(U,$J,358.3,1126,2)
+566 ;;=^5157261
+567 ;;^UTILITY(U,$J,358.3,1127,0)
+568 ;;=C92.40^^10^77^21
+569 ;;^UTILITY(U,$J,358.3,1127,1,0)
+570 ;;=^358.31IA^4^2
+571 ;;^UTILITY(U,$J,358.3,1127,1,3,0)
+572 ;;=3^Acute promyelocytic leukemia, not having achieved remission
+573 ;;^UTILITY(U,$J,358.3,1127,1,4,0)
+574 ;;=4^C92.40
+575 ;;^UTILITY(U,$J,358.3,1127,2)
+576 ;;=^5001801
+577 ;;^UTILITY(U,$J,358.3,1128,0)
+578 ;;=C92.50^^10^77^18
+579 ;;^UTILITY(U,$J,358.3,1128,1,0)
+580 ;;=^358.31IA^4^2
+581 ;;^UTILITY(U,$J,358.3,1128,1,3,0)
+582 ;;=3^Acute myelomonocytic leukemia, not having achieved remission
+583 ;;^UTILITY(U,$J,358.3,1128,1,4,0)
+584 ;;=4^C92.50
+585 ;;^UTILITY(U,$J,358.3,1128,2)
+586 ;;=^5001804
+587 ;;^UTILITY(U,$J,358.3,1129,0)
+588 ;;=C92.00^^10^77^15
+589 ;;^UTILITY(U,$J,358.3,1129,1,0)
+590 ;;=^358.31IA^4^2
+591 ;;^UTILITY(U,$J,358.3,1129,1,3,0)
+592 ;;=3^Acute myeloblastic leukemia, not having achieved remission
+593 ;;^UTILITY(U,$J,358.3,1129,1,4,0)
+594 ;;=4^C92.00
+595 ;;^UTILITY(U,$J,358.3,1129,2)
+596 ;;=^5001789
+597 ;;^UTILITY(U,$J,358.3,1130,0)
+598 ;;=C92.51^^10^77^17
+599 ;;^UTILITY(U,$J,358.3,1130,1,0)
+600 ;;=^358.31IA^4^2
+601 ;;^UTILITY(U,$J,358.3,1130,1,3,0)
+602 ;;=3^Acute myelomonocytic leukemia, in remission
+603 ;;^UTILITY(U,$J,358.3,1130,1,4,0)
+604 ;;=4^C92.51
+605 ;;^UTILITY(U,$J,358.3,1130,2)
+606 ;;=^5001805
+607 ;;^UTILITY(U,$J,358.3,1131,0)
+608 ;;=C92.41^^10^77^20
+609 ;;^UTILITY(U,$J,358.3,1131,1,0)
+610 ;;=^358.31IA^4^2
+611 ;;^UTILITY(U,$J,358.3,1131,1,3,0)
+612 ;;=3^Acute promyelocytic leukemia, in remission
+613 ;;^UTILITY(U,$J,358.3,1131,1,4,0)
+614 ;;=4^C92.41
+615 ;;^UTILITY(U,$J,358.3,1131,2)
+616 ;;=^5001802
+617 ;;^UTILITY(U,$J,358.3,1132,0)
+618 ;;=C92.01^^10^77^14
+619 ;;^UTILITY(U,$J,358.3,1132,1,0)
+620 ;;=^358.31IA^4^2
+621 ;;^UTILITY(U,$J,358.3,1132,1,3,0)
+622 ;;=3^Acute myeloblastic leukemia, in remission
+623 ;;^UTILITY(U,$J,358.3,1132,1,4,0)
+624 ;;=4^C92.01
+625 ;;^UTILITY(U,$J,358.3,1132,2)
+626 ;;=^5001790
+627 ;;^UTILITY(U,$J,358.3,1133,0)
+628 ;;=C92.02^^10^77^13
+629 ;;^UTILITY(U,$J,358.3,1133,1,0)
+630 ;;=^358.31IA^4^2
+631 ;;^UTILITY(U,$J,358.3,1133,1,3,0)
+632 ;;=3^Acute myeloblastic leukemia, in relapse
+633 ;;^UTILITY(U,$J,358.3,1133,1,4,0)
+634 ;;=4^C92.02
+635 ;;^UTILITY(U,$J,358.3,1133,2)
+636 ;;=^5001791
+637 ;;^UTILITY(U,$J,358.3,1134,0)
+638 ;;=C92.42^^10^77^19
+639 ;;^UTILITY(U,$J,358.3,1134,1,0)
+640 ;;=^358.31IA^4^2
+641 ;;^UTILITY(U,$J,358.3,1134,1,3,0)
+642 ;;=3^Acute promyelocytic leukemia, in relapse
+643 ;;^UTILITY(U,$J,358.3,1134,1,4,0)
+644 ;;=4^C92.42
+645 ;;^UTILITY(U,$J,358.3,1134,2)
+646 ;;=^5001803
+647 ;;^UTILITY(U,$J,358.3,1135,0)
+648 ;;=C92.52^^10^77^16
+649 ;;^UTILITY(U,$J,358.3,1135,1,0)
+650 ;;=^358.31IA^4^2
+651 ;;^UTILITY(U,$J,358.3,1135,1,3,0)
+652 ;;=3^Acute myelomonocytic leukemia, in relapse
+653 ;;^UTILITY(U,$J,358.3,1135,1,4,0)
+654 ;;=4^C92.52
+655 ;;^UTILITY(U,$J,358.3,1135,2)
+656 ;;=^5001806
+657 ;;^UTILITY(U,$J,358.3,1136,0)
+658 ;;=C92.10^^10^77^28
+659 ;;^UTILITY(U,$J,358.3,1136,1,0)
+660 ;;=^358.31IA^4^2
